New genetic screening program to find Plavix response

[News]

Beginning this month, all patients undergoing cardiac catheterization at Vanderbilt University Medical Center will be tested for a genetic variation that can affect their response to Plavix, the most commonly prescribed clot-preventing drug for heart patients and one of the most commonly prescribed drugs worldwide.

More... (http://www.news-medical.net/news/20100929/New-genetic-screening-program-to-find-Plavix-response.aspx)